Rheumatoid arthritis and myelodysplastic syndrome: a fortuitous association?

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Bulycheva E, Rauner M, Medyouf H, Theurl I, Bornhäuser M, Hofbauer LC, Platzbecker U (2015) Myelodysplasia is in the niche: novel concepts and emerging therapies. Leukemia. 29(2):259–268

    CAS  Article  Google Scholar 

  2. 2.

    Manganelli P, Delsante G, Bianchi G, Fietta P, Quaini F (2001) Remitting seronegative symmetrical synovitis with pitting oedema in a patient with myelodysplastic syndrome and relapsing polychondritis. Clin Rheumatol 20(2):132–135

    CAS  Article  Google Scholar 

  3. 3.

    Yano K, Eguchi K, Migita K, Takashima H, Tamura M, Izumino K, Sasagawa I, Sadamori N, Nagataki S (1996) Behçet’s disease complicated with myelodysplastic syndrome a report of two cases and review of the literature. Clin Rheumatol 15(1):91–93

    CAS  Article  Google Scholar 

  4. 4.

    Mekinian A, Braun T, Decaux O, Falgarone G, Toussirot E, Raffray L, Omouri M, Gombert B, de Wazieres B, Buchdaul AL, Ziza JM, Launay D, Denis G, Madaule S, Rose C, Grignano E, Fenaux P, Fain O, Club Rhumatismes et Inflammation (CRI), Groupe Francophone des Myélodysplasies (GFM), Société Nationale Française de Médecine Interne (SNFMI) (2014) Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases. Medicine. 93(1):1–10

    CAS  Article  Google Scholar 

  5. 5.

    Farmakis D, Polymeropoulos E, Polonifi A, Deftereos S, Giakoumi X, Floudas H, Grapsa A, Aessopos A (2005) Myelodysplastic syndrome associated with multiple autoimmune disorders. Clin Rheumatol 24(4):428–430

    Article  Google Scholar 

  6. 6.

    Mobini M, Shekarriz R, Ali Mohammad Pour R, Zakeri S (2015) Inflammatory rheumatologic disorders in patients with myelodysplastic syndromes: a cross-sectional study. Int J Hematol Oncol Stem Cell Res 9(1):22–25

    PubMed  PubMed Central  Google Scholar 

  7. 7.

    McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219

    CAS  Article  Google Scholar 

  8. 8.

    Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113(9):1271–1276

    CAS  Article  Google Scholar 

  9. 9.

    Murphy PT, Fay MJ, Swords RT, Quinn JP, O’Donnell JR (2004) Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis. Ann Pharmacother 38(11):1969–1970

    Article  Google Scholar 

  10. 10.

    Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239–245

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zakaria El Ouali.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

El Ouali, Z., Nassar, K. & Janani, S. Rheumatoid arthritis and myelodysplastic syndrome: a fortuitous association?. Clin Rheumatol 39, 2829–2831 (2020). https://doi.org/10.1007/s10067-020-05092-6

Download citation